Pasithea Therapeutics Corp.
Last updated September 27, 2026
Organization details
- Legal name
- Pasithea Therapeutics Corp.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Miami Beach
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KTTA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001841330
- EIN
- 85-1591963
Board of directors
-
Alfred J. Novak · DirectorSince 2024
-
Emer Leahy · DirectorSince 2024
-
Lawrence Steinman · DirectorSince 2023
-
Simon Dumesnil · DirectorSince 2024
-
Tiago Marques · Director · Chief Executive OfficerSince 2024
Chief executives
Tiago Marques
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of September 3, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.3%
-
98.0%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Lawrence Steinman
- via Emer Leahy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $202,999
- 4 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +100,000 | $0.53 | $53,000 |
| Nov 28, 2025 | Lawrence Steinman Director | Open-market purchase | +133,333 | $0.75 | $100,000 |
| Nov 28, 2025 | Schneiderman Daniel H Officer (Chief Financial Officer) | Grant or award | +26,667 | $0.75 | $20,000 |
| Nov 28, 2025 | Tiago Marques Director, Officer (Chief Executive Officer) | Open-market purchase | +33,333 | $0.75 | $25,000 |
| Nov 28, 2025 | Simon Dumesnil Director | Open-market purchase | +33,333 | $0.75 | $25,000 |
| Nov 28, 2025 | Emer Leahy Director | Grant or award | +33,333 | $0.75 | $25,000 |
| May 12, 2025 | Tiago Marques Director, Officer (Chief Executive Officer) | Open-market sale | −960 | $0.83 | $797 |
| Jun 13, 2024 | Alfred J. Novak Director | Grant or award | +2,750 | $5.62 | $15,455 |
| Jun 12, 2024 | Alfred J. Novak Director | Grant or award | +750 | $5.61 | $4,208 |
| Jun 2, 2023 | Lawrence Steinman Director | Open-market purchase | +30,000 | $0.43 | $12,900 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.